[1]
Faiza Fatima et al. 2026. Zongertinib in HER2-Mutant Advanced/Metastatic Solid Tumors: A Narrative Review and Future Prospectives. Journal of Cancer Biomoleculars and Therapeutics. 3, 2 (Apr. 2026), 13–24. DOI:https://doi.org/10.62382/jcbt.v3i2.99.